The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1)
- PMID: 20144468
- DOI: 10.1016/j.virol.2010.01.009
The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1)
Abstract
E5 oncoprotein activity from high risk human papillomaviruses (HPVs) is associated with growth factor receptor signaling, but the function of this protein is not well understood. In this study, we investigated the role of HPV-16 E5 on the cell cycle progression during EGF-stimulation. Wild-type and NIH 3T3 cells over-expressing human EGF-receptor were transfected with HPV-16 E5 gene and the cell cycle progression was characterized. This analysis showed that the E5-expressing cells increased DNA synthesis (S-phase) by around 40%. Cell cycle protein analysis of E5-expressing cells showed a reduction in the half-life of p27(Kip1) protein as compared to control cells (18.4 vs. 12.7 h), an effect that was enhanced in EGF-stimulated cells (12.8 vs. 3.6 h). Blockage of EGF-receptor activity abrogated E5 signals as well as p27(Kip1) down-regulation. These results suggest that E5 and the EGF-receptor cooperate to enhance cell cycle entry and progression through regulating p27(Kip1) expression at protein level.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.J Virol. 2010 Oct;84(20):10619-29. doi: 10.1128/JVI.00831-10. Epub 2010 Aug 4. J Virol. 2010. PMID: 20686024 Free PMC article.
-
Cell transformation by the E5/E8 protein of bovine papillomavirus type 4. p27(Kip1), Elevated through increased protein synthesis is sequestered by cyclin D1-CDK4 complexes.J Biol Chem. 2001 Sep 7;276(36):33861-8. doi: 10.1074/jbc.M100958200. Epub 2001 Jul 11. J Biol Chem. 2001. PMID: 11448948
-
Cyclin A expression and growth in suspension can be uncoupled from p27 deregulation and extracellular signal-regulated kinase activity in cells transformed by bovine papillomavirus type 4 E5.J Gen Virol. 2004 Dec;85(Pt 12):3585-3595. doi: 10.1099/vir.0.80313-0. J Gen Virol. 2004. PMID: 15557231
-
Impact of HPV E5 on viral life cycle via EGFR signaling.Microb Pathog. 2020 Feb;139:103923. doi: 10.1016/j.micpath.2019.103923. Epub 2019 Dec 11. Microb Pathog. 2020. PMID: 31836496 Review.
-
Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation.Mol Cancer Res. 2021 Feb;19(2):167-179. doi: 10.1158/1541-7786.MCR-20-0491. Epub 2020 Oct 26. Mol Cancer Res. 2021. PMID: 33106372 Review.
Cited by
-
The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.J Gen Virol. 2021 Mar;102(3):001540. doi: 10.1099/jgv.0.001540. Epub 2021 Jan 11. J Gen Virol. 2021. PMID: 33427604 Free PMC article. Review.
-
Mucosal and Cutaneous Human Papillomavirus Infections and Cancer Biology.Front Oncol. 2019 May 8;9:355. doi: 10.3389/fonc.2019.00355. eCollection 2019. Front Oncol. 2019. PMID: 31134154 Free PMC article. Review.
-
A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism.PLoS One. 2022 Dec 12;17(12):e0278058. doi: 10.1371/journal.pone.0278058. eCollection 2022. PLoS One. 2022. PMID: 36508448 Free PMC article.
-
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value.Cell Oncol (Dordr). 2012 Apr;35(2):67-76. doi: 10.1007/s13402-011-0069-x. Epub 2012 Jan 20. Cell Oncol (Dordr). 2012. PMID: 22262402 Review.
-
Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway.Cell Rep. 2023 May 30;42(5):112508. doi: 10.1016/j.celrep.2023.112508. Epub 2023 May 11. Cell Rep. 2023. PMID: 37171962 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous